Literature DB >> 1452767

The sensitivity of the Mini-Mental State Exam in the white matter dementia of multiple sclerosis.

T Swirsky-Sacchetti1, H L Field, D R Mitchell, J Seward, F D Lublin, R L Knobler, C F Gonzalez.   

Abstract

Fifty-six patients diagnosed with definite multiple sclerosis (MS) according to Poser criteria were administered the Mini-Mental State Examination (MMSE) and a comprehensive battery of neuropsychological tests. Extent of cerebral lesion involvement was determined by quantitative magnetic resonance imaging (MRI) ratings. The MMSE correlated with overall levels of physical disability, but did not correlate with total lesion area on MRI. Sensitivity of the MMSE to the subcortical dementia of MS was low (28%) when performance on the neuropsychological testing battery was used as the criterion. Impairment on tests of memory, speed of information processing, abstract reasoning, naming/verbal fluency, as well as visuoperceptual organization, were correlated highly with total lesion area on MRI. The low sensitivity of the MMSE to cognitive impairment in MS is discussed in terms of its item composition and the characteristic pattern of deficits found in MS.

Entities:  

Mesh:

Year:  1992        PMID: 1452767     DOI: 10.1002/1097-4679(199211)48:6<779::aid-jclp2270480612>3.0.co;2-b

Source DB:  PubMed          Journal:  J Clin Psychol        ISSN: 0021-9762


  14 in total

Review 1.  Cognitive screening in multiple sclerosis.

Authors:  Peter Scherer
Journal:  J Neurol       Date:  2007-05       Impact factor: 4.849

2.  Neuroimaging signatures and cognitive correlates of the montreal cognitive assessment screen in a nonclinical elderly sample.

Authors:  Robert Paul; Elizabeth M Lane; David F Tate; Jodi Heaps; Dana M Romo; Erbil Akbudak; Jennifer Niehoff; Thomas E Conturo
Journal:  Arch Clin Neuropsychol       Date:  2011-06-04       Impact factor: 2.813

3.  White matter dementia.

Authors:  Christopher M Filley
Journal:  Ther Adv Neurol Disord       Date:  2012-09       Impact factor: 6.570

4.  High concurrent presence of disability in multiple sclerosis. Associations with perceived health.

Authors:  Sverker Johansson; Charlotte Ytterberg; Ingrid M Claesson; Jenny Lindberg; Jan Hillert; Magnus Andersson; Lotta Widén Holmqvist; Lena von Koch
Journal:  J Neurol       Date:  2007-04-02       Impact factor: 4.849

5.  Evaluation of retinal and choroidal changes in patients with Alzheimer's type dementia using optical coherence tomography angiography.

Authors:  Ze-Bing Li; Zhong-Jing Lin; Na Li; Huan Yu; Yan-Lin Wu; Xi Shen
Journal:  Int J Ophthalmol       Date:  2021-06-18       Impact factor: 1.779

Review 6.  Neuropsychological impairment in systemic lupus erythematosus: a comparison with multiple sclerosis.

Authors:  R H B Benedict; J L Shucard; R Zivadinov; D W Shucard
Journal:  Neuropsychol Rev       Date:  2008-06-03       Impact factor: 7.444

Review 7.  How the conflict between American psychiatry and neurology delayed the appreciation of cognitive dysfunction in multiple sclerosis.

Authors:  Michelle A Butler; John R Corboy; Christopher M Filley
Journal:  Neuropsychol Rev       Date:  2009-04-17       Impact factor: 7.444

Review 8.  Neuropsychological aspects of multiple sclerosis.

Authors:  J C Brassington; N V Marsh
Journal:  Neuropsychol Rev       Date:  1998-06       Impact factor: 7.444

9.  Attention related performance in two cognitively different subgroups of patients with multiple sclerosis.

Authors:  P Kujala; R Portin; A Revonsuo; J Ruutiainen
Journal:  J Neurol Neurosurg Psychiatry       Date:  1995-07       Impact factor: 10.154

Review 10.  Understanding the Outcomes Measures used in Huntington Disease Pharmacological Trials: A Systematic Review.

Authors:  Noelle E Carlozzi; Angela Miciura; Nicholas Migliore; Praveen Dayalu
Journal:  J Huntingtons Dis       Date:  2014
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.